Barclays analyst Blayne Curtis maintains Texas Instruments (NASDAQ:TXN) with a Equal-Weight and raises the price target from $150 to $165.
The Latest Analyst Ratings for Nurix Therapeutics
Nurix Therapeutics (NASDAQ:NRIX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…